Y Intercept (Hong Kong) LTD Beam Therapeutics Inc. Transaction History

Y Intercept (Hong Kong) LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$36.73 - $51.6 $253,841 - $356,607	-6,911 Closed	0 $0
Q3 2022 Feb 14, 2023	BUY	$39.79 - $70.31 $274,988 - $485,912	6,911 New	6,911 $329,000
Q3 2021 Nov 15, 2021	SELL	$84.37 - $133.6 $696,896 - $1.1 Million	-8,260 Closed	0 $0
Q2 2021 Aug 26, 2021	BUY	$64.12 - $128.71 $529,631 - $1.06 Million	8,260 New	8,260 $1.06 Million
Q2 2021 Aug 12, 2021	SELL	$64.12 - $128.71 $207,107 - $415,733	-3,230 Closed	0 $1.06 Million
Q1 2021 May 12, 2021	BUY	$71.28 - $120.75 $230,234 - $390,022	3,230 New	3,230 $245,000

236

75.2M

438K

232K

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

Get notified when there are updates to the investment portfolio of Y Intercept (Hong Kong) LTD, based on Form 13F filings with the SEC.

Stay updated on Y Intercept (Hong Kong) LTD with notifications on news.